Repair of Mitral Prolapse: Comparison of Thoracoscopic Minimally-invasive and Conventional Approaches.

Abstract

Surgical repair remains the best treatment for severe primary mitral regurgitation. Minimally invasive mitral valve surgery is being increasingly performed, but there is a lack of solid evidence comparing thoracoscopic with conventional surgery. Our objective was to compare outcomes of both approaches for repair of leaflet prolapse. All consecutive patients undergoing surgery for severe mitral regurgitation due to mitral prolapse from 2012 to 2020 were evaluated according to the approach used. Freedom from mortality, reoperation and recurrent severe mitral regurgitation were evaluated by Kaplan-Meier method. Differences in baseline characteristics were adjusted with propensity score matched analysis (1:1, nearest neighbor). 300 patients met inclusion criteria and were divided into thoracoscopic (N = 188) and conventional (sternotomy; N = 112) groups. Unmatched patients in the thoracoscopic group were younger and had lower body mass index, New York Heart Association class and EuroSCORE-II preoperatively. After matching, thoracoscopic group presented significantly shorter mechanical ventilation (9 vs.15h), shorter intensive care unit stay (41 vs 65 h) and higher postoperative hemoglobin levels (11 vs.10.2 mg/dL) despite longer bypass and cross-clamp times (+30 and +17min). There were no differences in mortality or mitral regurgitation grade at discharge between groups nor differences in survival, repair failures and reinterventions during follow-up. Minimally invasive mitral repair can be performed in the majority of patients with mitral prolapse, without compromising outcomes, repair rate or durability, while providing shorter mechanical ventilation and intensive care unit stay and less blood loss.